People · Operator
Named in public records as an officer, director or promoter · active 2019–2024 · Healthtech, Biotechnology, Medical Devices
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Applaud Medical, Inc. | — | Healthtech | Series B | $38.0M | $44.1M | 2020 |
| Blue Lake Biotechnology, Inc. | — | Biotechnology | Series A | $18.8M | $153.7M | 2019 |
| Nanomedical Diagnostics, Inc. | — | Medical Devices | Series A | $12.0M | $37.9M | 2020 |
| BioEclipse Therapeutics, Inc. | — | Biotechnology | Series A | $10.1M | $366.1M | 2019 |
| Avotres Inc. | — | Biotechnology | Seed | $8.0M | $36.9M | 2020 |
Biao He at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Biao He on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ben Zadik | 1 | 6 |
| Elona Baum | 1 | 5 |
| Paul Grint | 1 | 5 |
| Nina Saberi | 1 | 5 |
| Joseph Keegan | 1 | 4 |
| Stephen Thau | 1 | 4 |
| Thomas Kenny | 1 | 4 |
| John Garcia | 1 | 3 |
| ALEX ANDRIANOPOULOS | 1 | 3 |
| Mark Frohlich | 1 | 3 |
| Paul Molloy | 1 | 3 |
| Catherine Sohn | 1 | 3 |
| Michael Heltzen | 1 | 2 |
| Quinten Stevens | 1 | 2 |
| Tim Hoerr | 1 | 2 |
| Gordon Saul | 1 | 2 |
| Rich Ganz | 1 | 2 |
| Ross Bundy | 1 | 2 |
| Bruce Cooper | 1 | 2 |
| Alex Li | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.